Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Pancreatic stellate cells (PSCs) differentiate into cancer-associated fibroblasts (CAFs) that produce desmoplastic stroma, thereby modulating disease progression and therapeutic response in pancreatic ductal adenocarcinoma (PDA). However, it is unknown whether CAFs uniformly carry out these tasks or if subtypes of CAFs with distinct phenotypes in PDA exist. We identified a CAF subpopulation with elevated expression of α-smooth muscle actin (αSMA) located immediately adjacent to neoplastic cells in mouse and human PDA tissue. We recapitulated this finding in co-cultures of murine PSCs and PDA organoids, and demonstrated that organoid-activated CAFs produced desmoplastic stroma. The co-cultures showed cooperative interactions and revealed another distinct subpopulation of CAFs, located more distantly from neoplastic cells, which lacked elevated αSMA expression and instead secreted IL6 and additional inflammatory mediators. These findings were corroborated in mouse and human PDA tissue, providing direct evidence for CAF heterogeneity in PDA tumor biology with implications for disease etiology and therapeutic development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Finally, TGF-β influences CAF expression of cytokines and chemokines that act on cancer, endothelial and/or immune cells, such as HGF245, VEGF, IL-6, IL-8, MCP1, PGE2 and CXCL12229,257–262.”
From TGFβ biology in cancer progression and immunotherapy (2021) · cites this paper as [229]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In pancreatic cancer, CAFs most proximal to the cancer cells exhibit a myoCAF phenotype, with high TGFβ-driven αSMA expression and a contractile phenotype33.”
From A framework for advancing our understanding of cancer-associated fibroblasts (2020) · cites this paper as [33]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“With respect to CAFs and pancreatic cancer, it has been established that coculture of murine PSCs and PDAC tumor organoids leads to CAF differentiation into two subtypes -one with elevated expression of α -SMA (myo fi broblast-like CAFs) and the other with high expression of IL-6 (in fl ammatory CAFs) [61].”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [61]
The cited source says what the claim attributes to it.
In the citing paper
“CAFs that are in close proximity to cancer cells present a myo fi broblast-like phenotype (myCAF) de fi ned by a high expression of α -SMA”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [61]
The cited source says what the claim attributes to it.
In the citing paper
“whereas CAFs distant from cancer cells barely express α -SMA but secrete high amounts of in fl ammatory cytokine IL-6 (iCAF)”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [61]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Differential expression analysis for sequence count data
Anders, S., & Huber, W. (2010) · Genome Biology · doi:10.1186/gb-2010-11-10-r106 · Cited by 15,581
Trapnell, C., Williams, B. A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M. J., Salzberg, S. L., Wold, B. J., & Pachter, L. (2010) · Nature Biotechnology · doi:10.1038/nbt.1621 · Cited by 15,556
TopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,617
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Self-citationCre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus
Srinivas, S., Watanabe, T., Lin, C.-S., William, C. M., Tanabe, Y., Jessell, T. M., & Costantini, F. (2001) · BMC Developmental Biology · doi:10.1186/1471-213x-1-4 · Cited by 3,121
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681
Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
Self-citation
Cited by
Items 801–900 of 1,008
Turan, T., Kongpachith, S., Halliwill, K. D., Roelands, J. P., Hendrickx, W., Marincola, F. M., Hudson, T. J., Jacob, H. J., Bedognetti, D., Samayoa, J. A., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01145-4 · Cited by 43
Chen, H., Yang, W., Xue, X., Li, Y., Jin, Z., & Ji, Z. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415970 · Cited by 44
Perspectives on Hypoxia Signaling in Tumor Stroma
Zhang, Y., Coleman, M., & Brekken, R. A. (2021) · Cancers · doi:10.3390/cancers13123070 · Cited by 39
Fibroblast heterogeneity in prostate carcinogenesis
ChallaSivaKanaka, S., Vickman, R. E., Kakarla, M., Hayward, S. W., & Franco, O. E. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.10.028 · Cited by 43
Lung cancer organoids, a promising model still with long way to go
Ma, H., Zhu, Y.-J., Zhou, R., Yu, Y., Xiao, Z., & Zhang, H.-B. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103610 · Cited by 45
Cancer-Associated Fibroblasts: Lessons from Pancreatic Cancer
Sherman, M. H., & di Magliano, M. P. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-061421-035400 · Cited by 42
The role of cancer-associated fibroblasts in breast cancer metastasis
Li, Y., Wang, C., Huang, T. H., Yu, X., & Tian, B. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1194835 · Cited by 48
Knipper, K., Lyu, S. I., Quaas, A., Bruns, C. J., & Schmidt, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713482 · Cited by 46
Kazakova, A. N., Lukina, M. M., Anufrieva, K. S., Bekbaeva, I. V., Ivanova, O. M., Shnaider, P. V., Slonov, A. V., Arapidi, G. P., & Shender, V. О. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1403122 · Cited by 50
Hou, W. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1602452 · Cited by 45
Shi, W., Zhang, Z., Xu, X., Tian, Y., Feng, L., Huang, X., Du, Y., & Li, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1649468 · Cited by 57
High‐grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF‐1
Steins, A., van Mackelenbergh, M. G., van der Zalm, A. P., Klaassen, R., Serrels, B., Goris, S. G., Kocher, H. M., Waasdorp, C., de Jong, J. H., Tekin, C., et al. (2020) · EMBO reports · doi:10.15252/embr.201948780 · Cited by 39
Pancreatic Cancer Molecular Classifications: From Bulk Genomics to Single Cell Analysis
Pompella, L., Tirino, G., Pappalardo, A., Caterino, M., Ventriglia, A., Nacca, V., Orditura, M., Ciardiello, F., & Vita, F. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082814 · Cited by 43
Minimal Residual Disease, Metastasis and Immunity
Badia-Ramentol, J., Linares, J., Gómez‐Llonín, A., & Calon, A. (2021) · Biomolecules · doi:10.3390/biom11020130 · Cited by 44
Yang, J., Huang, S., Cheng, S., Jin, Y., Zhang, N., & Wang, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.701429 · Cited by 42
Photodynamic Therapy for Pancreatic Ductal Adenocarcinoma
Karimnia, V., Slack, F. J., & Celli, J. P. (2021) · Cancers · doi:10.3390/cancers13174354 · Cited by 47
Becker, L., Janssen, N., Layland, S. L., Mürdter, T. E., Nies, A. T., Schenke‐Layland, K., & Marzi, J. (2021) · Cancers · doi:10.3390/cancers13225682 · Cited by 48
Fibroblast-derived prolargin is a tumor suppressor in hepatocellular carcinoma
Chiavarina, B., Ronca, R., Otaka, Y., Sutton, R. B., Rezzola, S., Yokobori, T., Chiodelli, P., Souche, F.-R., Pourquier, D., Maraver, A., et al. (2022) · Oncogene · doi:10.1038/s41388-021-02171-z · Cited by 46
Ganguly, K., Cox, J. L., Ghersi, D., Grandgenett, P. M., Hollingsworth, M. A., Jain, M., Kumar, S., & Batra, S. K. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.02.032 · Cited by 41
Meng, Q., Luo, X., Chen, J., Wang, D., Chen, E., Zhang, W., Zhang, G., Zhou, W., Xu, J., & Song, Z. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188443 · Cited by 39
Modeling Pancreatic Cancer with Patient-Derived Organoids Integrating Cancer-Associated Fibroblasts
Go, Y.-H., Choi, W. H., Bae, W. J., Jung, S., Cho, C., Lee, S. A., Park, J. S., Ahn, J. M., Kim, S. W., Lee, K. J., et al. (2022) · Cancers · doi:10.3390/cancers14092077 · Cited by 43
Patient-derived Tumour Organoids: A Bridge between Cancer Biology and Personalised Therapy
Wu, W., Li, X., & Yu, S. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.04.050 · Cited by 42
Vienot, A., Pallandre, J., Renaude, E., Viot, J., Bouard, A., Spehner, L., Kroemer, M., Abdeljaoued, S., van der Woning, B., de Haard, H., et al. (2022) · OncoImmunology · doi:10.1080/2162402x.2022.2144669 · Cited by 40
Naito, Y., Yoshioka, Y., & Ochiya, T. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02784-8 · Cited by 44
Dual Role of Fibroblasts Educated by Tumour in Cancer Behavior and Therapeutic Perspectives
Toledo, B., Picon‐Ruiz, M., Marchal, J. A., & Perán, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415576 · Cited by 42
Milosevic, V., & Östman, A. (2024) · Upsala Journal of Medical Sciences · doi:10.48101/ujms.v129.10710 · Cited by 49
Huang, Z., Chen, J., Zhu, T., Li, J., Ng, H. Y., Zhou, Y., Gu, X., Xu, S., & Jia, R. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02533-1 · Cited by 66
Pitarresi, J. R., Liu, X., Avendano, A., Thies, K., Sizemore, G. M., Hammer, A. M., Hildreth, B. E., Wang, J., Steck, S., Donohue, S., et al. (2018) · Life Science Alliance · doi:10.26508/lsa.201800190 · Cited by 39
Non-Coding RNAs as Regulators and Markers for Targeting of Breast Cancer and Cancer Stem Cells
Prabhu, K. S., Raza, A., Karedath, T., Raza, S. S., Fathima, H., Ahmed, E. I., Kuttikrishnan, S., Therachiyil, L., Kuliński, M., Dermime, S., et al. (2020) · Cancers · doi:10.3390/cancers12020351 · Cited by 39
Heterotypic 3D pancreatic cancer model with tunable proportion of fibrotic elements
Tanaka, H. Y., Kurihara, T., Nakazawa, T., Matsusaki, M., Masamune, A., & Kano, M. R. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120077 · Cited by 39
Ritchie, S., Reed, D. A., Pereira, B., & Timpson, P. (2021) · Faculty Reviews · doi:10.12703/r/10-4 · Cited by 47
Genomic Heterogeneity of Pancreatic Ductal Adenocarcinoma and Its Clinical Impact
Gutiérrez, M. L., Muñoz‐Bellvís, L., & Órfão, A. (2021) · Cancers · doi:10.3390/cancers13174451 · Cited by 43
Nissen, N. I., Johansen, A. Z., Chen, I. M., Johansen, J. S., Pedersen, R. S., Hansen, C. P., Karsdal, M. A., & Willumsen, N. (2022) · Cancers · doi:10.3390/cancers14030819 · Cited by 45
Murphy, K. J., Chambers, C. R., Herrmann, D., Timpson, P., & Pereira, B. (2021) · Cancers · doi:10.3390/cancers13143481 · Cited by 45
Yang, W., Zhang, S., Li, T., Zhou, Z., & Pan, J. (2022) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2022132 · Cited by 49
An integrated map of fibroblastic populations in human colon mucosa and cancer tissues
Li, S., Lu, R., Shu, L., Chen, Y., Zhao, J., Dai, J., Huang, Q., Li, X., Meng, W., Long, F., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-04298-5 · Cited by 40
Tanaka, H. Y., Nakazawa, T., Enomoto, A., Masamune, A., & Kano, M. R. (2023) · Cancers · doi:10.3390/cancers15030724 · Cited by 46
Liu, X., Liu, Y., Xu, J., Zhang, Y., Ruan, Y., Zhao, Y., Wu, L., Hu, J., Zhang, Z., He, M., et al. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1203 · Cited by 45
Tajaldini, M., Poorkhani, A., Amiriani, T., Amiriani, A., Javid, H., Aref, P., Ahmadi, F., Sadani, S., & Khori, V. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175991 · Cited by 40
Takeuchi, K., Tabe, S., Takahashi, K., Aoshima, K., Matsuo, M., Ueno, Y., Furukawa, Y., Yamaguchi, K., Ohtsuka, M., Morinaga, S., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113420 · Cited by 41
Kabiljo, J., Theophil, A., Homola, J., Renner, A. F., Stürzenbecher, N., Ammon, D., Zirnbauer, R., Stang, S., Tran, L., Laengle, J., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-009494 · Cited by 40
The identification of new biomarkers for bladder cancer: A study based on TCGA and GEO datasets
Hu, J., Zhou, L., Song, Z., Xiong, M., Zhang, Y., Yang, Y., Chen, K., & Chen, Z. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28208 · Cited by 45
Johnson, J., Sharick, J. T., Skala, M. C., & Li, L. (2019) · Journal of Mass Spectrometry · doi:10.1002/jms.4452 · Cited by 40
Rai, A., Greening, D. W., Xu, R., Suwakulsiri, W., & Simpson, R. J. (2020) · PROTEOMICS · doi:10.1002/pmic.202000016 · Cited by 36
The actin modulator hMENA regulates GAS6‐AXL axis and pro‐tumor cancer/stromal cell cooperation
Melchionna, R., Spada, S., Modugno, F. D., D’Andrea, D., Carlo, A. D., Panetta, M., Mileo, A. M., Sperduti, I., Antoniani, B., Gallo, E., et al. (2020) · EMBO Reports · doi:10.15252/embr.202050078 · Cited by 37
The Biological and Biomechanical Role of Transglutaminase-2 in the Tumour Microenvironment
Tempest, R., Guarnerio, S., Maani, R., Cooper, J., & Peake, N. (2021) · Cancers · doi:10.3390/cancers13112788 · Cited by 41
Gao, L., Morine, Y., Yamada, S., Saito, Y., Ikemoto, T., Tokuda, K., Miyazaki, K., Okikawa, S., Takasu, C., & Shimada, M. (2021) · Cancer Science · doi:10.1111/cas.15041 · Cited by 38
Li, Y., Xu, F., Chen, F., Chen, Y., Ge, D., Zhang, S., & Lu, C. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103510 · Cited by 41
Willumsen, N., Jensen, C., Green, G. A., Nissen, N. I., Neely, J., Nelson, D. M., Pedersen, R. S., Frederiksen, P., Chen, I. M., Boisen, M. K., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04226-0 · Cited by 40
Liu, T., Zhou, L., Xiao, Y., Andl, T., & Zhang, Y. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-0614 · Cited by 40
Strating, E., Wassenaar, E., Verhagen, M., Rauwerdink, P., van Schelven, S., de Hingh, I., Rinkes, I. B., Boerma, D., Witkamp, A., Lacle, M., et al. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01748-z · Cited by 36
Cancer-Associated Fibroblast Diversity Shapes Tumor Metabolism in Pancreatic Cancer
Peiffer, R., Boumahd, Y., Gullo, C., Crake, R., Letellier, E., Bellahcène, A., & Peulen, O. (2022) · Cancers · doi:10.3390/cancers15010061 · Cited by 38
Lim, J. U., Lee, E., Lee, S., Cho, H. J., Ahn, D. H., Hwang, Y., Choi, J. Y., Yeo, C. D., Park, C. K., & Kim, S. J. (2023) · Translational Lung Cancer Research · doi:10.21037/tlcr-22-633 · Cited by 45
Self-citationCancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
Martínez-Zubiaurre, I., & Hellevik, T. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01093-5 · Cited by 40
Nakazawa, Y., Miyano, M., Tsukamoto, S., Kogai, H., Yamamoto, A., Iso, K., Inoue, S., Yamane, Y., Yabe, Y., Umihara, H., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46167-1 · Cited by 44
Cross-Talk Between Cancer and Its Cellular Environment—A Role in Cancer Progression
Turlej, E., Domaradzka, A., Radzka, J., Drulis‐Fajdasz, D., Kulbacka, J., & Gizak, A. (2025) · Cells · doi:10.3390/cells14060403 · Cited by 50
Sun, X., Cai, W., Li, H., Gao, C., Ma, X., Guo, Y. L., Fu, D., Xiao, D., Zhang, Z., Wang, Y., et al. (2025) · Gut · doi:10.1136/gutjnl-2024-333638 · Cited by 45
Organoids Provide an Important Window on Inflammation in Cancer
Baker, K. (2018) · Cancers · doi:10.3390/cancers10050151 · Cited by 41
Role of Schwann cells in cutaneous wound healing
da Silva, W. N., Leonel, C., Prazeres, P. H. D. M., Sena, I. F. G., Guerra, D. A. P., Heller, D., Diniz, I. M. A., Fortuna, V., Mintz, A., & Birbrair, A. (2018) · Wound Repair and Regeneration · doi:10.1111/wrr.12647 · Cited by 37
Dzobo, K., Rowe, A., Senthebane, D. A., AlMazyadi, M., Patten, V. A., & Parker, M. I. (2018) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2018.0172 · Cited by 38
Lenggenhager, D. M., Amrutkar, M., Sántha, P., Aasrum, M., Löhr, M. J., Gladhaug, I. P., & Verbeke, C. S. (2019) · Cells · doi:10.3390/cells8010023 · Cited by 36
Nanomedicine for Imaging and Therapy of Pancreatic Adenocarcinoma
Brachi, G., Bussolino, F., Ciardelli, G., & Mattu, C. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00307 · Cited by 38
Engineering clinically-relevant human fibroblastic cell-derived extracellular matrices
Franco‐Barraza, J., Raghavan, K. S., Luong, T., & Cukierman, E. (2020) · Methods in cell biology · doi:10.1016/bs.mcb.2019.11.014 · Cited by 39
Liu, H., Tao, H., Wang, H., Yang, Y., Yang, R., Dai, X., Ding, X., Wu, H., Chen, S., & Sun, T. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.619317 · Cited by 37
Moore, A. M., Zhou, L., Cui, J., Li, L., Wu, N., Yu, A. C., Poddar, S., Liang, K., Abt, E. R., Kim, S., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2012469118 · Cited by 42
Organ-Chip Models: Opportunities for Precision Medicine in Pancreatic Cancer
Haque, M. R., Rempert, T. H., Al-Hilal, T. A., Wang, C., Bhushan, A., & Bishehsari, F. (2021) · Cancers · doi:10.3390/cancers13174487 · Cited by 36
Pancreatic Ductal Adenocarcinoma: Preclinical in vitro and ex vivo Models
Gündel, B., Liu, X., Löhr, M. J., & Heuchel, R. L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.741162 · Cited by 47
Cell Lineage Infidelity in PDAC Progression and Therapy Resistance
Malinova, A., Veghini, L., Real, F. X., & Corbo, V. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.795251 · Cited by 42
Self-citationThe ABCs of Antigen Presentation by Stromal Non-Professional Antigen-Presenting Cells
Harryvan, T. J., de Lange, S., Hawinkels, L. J. A. C., & Verdegaal, E. M. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010137 · Cited by 44
Targeting hedgehog signaling in pancreatic ductal adenocarcinoma
Quatannens, D., Verhoeven, Y., van Dam, P. A., Lardon, F., Prenen, H., Roeyen, G., Peeters, M., Smits, E., & Audenaerde, J. R. M. V. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108107 · Cited by 40
Combinatorial Gli activity directs immune infiltration and tumor growth in pancreatic cancer
Scales, M. K., Velez-Delgado, A., Steele, N. G., Schrader, H. E., Stabnick, A. M., Yan, W., Soto, N. M. M., Nwosu, Z. C., Johnson, C. N., Zhang, Y., et al. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010315 · Cited by 38
Reprogramming of central carbon metabolism in hepatocellular carcinoma
Xia, H., Huang, Z., Xu, Y., Yam, J. W. P., & Cui, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113485 · Cited by 46
Exploiting the STAT3 Nexus in Cancer-Associated Fibroblasts to Improve Cancer Therapy
Allam, A. H., Yakou, M. H., Pang, L., Ernst, M., & Huynh, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.767939 · Cited by 42
Rizzo, R., Onesto, V., Forciniti, S., Chandra, A., Prasad, S., Iuele, H., Colella, F., Gigli, G., & del Mercato, L. L. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114401 · Cited by 40
Al‐Hamaly, M. A., Turner, L. T., Rivera-Martinez, A., Rodriguez, A., & Blackburn, J. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032288 · Cited by 44
González‐Callejo, P., Gener, P., Díaz‐Riascos, Z. V., Conti, S., Cámara‐Sánchez, P., Riera, R., Mancilla, S., García‐Gabilondo, M., Peg, V., Arango, D., et al. (2023) · International Journal of Cancer · doi:10.1002/ijc.34447 · Cited by 38
Minini, M., & Fouassier, L. (2023) · Current Oncology · doi:10.3390/curroncol30040319 · Cited by 40
George, B., Kudryashova, O. M., Kravets, A. D., Thalji, S. Z., Malarkannan, S., Kurzrock, R., Chernyavskaya, E. F., Gusakova, M., Kravchenko, D., Tychinin, D. I., et al. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.01.028 · Cited by 37
Adem, B., Bastos, N., Ruivo, C. F., Sousa-Alves, S., Dias, C., Vieira, P. F., Batista, I. A., Cavadas, B., Saur, D., Machado, J. C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45753-7 · Cited by 40
The Application of Nanoparticles Targeting Cancer-Associated Fibroblasts
Huang, Q., Ge, Y., He, Y. T., Wu, J., Tong, Y., Shang, H., Liu, X., Ba, X., Xia, D., Peng, E., et al. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s447350 · Cited by 37
Engineered biological nanoparticles as nanotherapeutics for tumor immunomodulation
Rahmat, J. N., Liu, J., Chen, T., Li, Z., & Zhang, Y. (2024) · Chemical Society Reviews · doi:10.1039/d3cs00602f · Cited by 45
Raffo‐Romero, A., Ziane-Chaouche, L., Salomé‐Desnoulez, S., Hajjaji, N., Fournier, I., Salzet, M., & Duhamel, M. (2024) · Cell Reports Methods · doi:10.1016/j.crmeth.2024.100792 · Cited by 44
Transcriptome Landscape of Cancer‐Associated Fibroblasts in Human PDAC
Tao, M., Liu, W., Chen, J., Liu, R., Zou, J., Yu, B., Wang, C., Huang, M., Chen, Q., Zhang, Z., et al. (2025) · Advanced Science · doi:10.1002/advs.202415196 · Cited by 63
Fibroblast atlas: Shared and specific cell types across tissues
Liu, K., Cui, Y., Han, H., Guo, E., Shi, X., Xiong, K., Zhang, N., Zhai, S., Sang, S., Liu, M., et al. (2025) · Science Advances · doi:10.1126/sciadv.ado0173 · Cited by 48
PGE2 in fibrosis and cancer: Insights into fibroblast activation
Elwakeel, E., Brüne, B., & Weigert, A. (2019) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2019.106339 · Cited by 42
Cao, H., Cheng, H. S., Wang, J. K., Tan, N. S., & Tay, C. Y. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.03.037 · Cited by 39
Pericytes cross-talks within the tumor microenvironment
Picoli, C. C., Gonçalves, B. Ô. P., Santos, G. S. P., Rocha, B. G. S., Costa, A. C., Resende, R. R., & Birbrair, A. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188608 · Cited by 36
Chen, H., Li, Z., Meng, Y., Qian, X., Fan, Y., Zhang, Q., Wang, C., Lin, F., Chen, B., Xu, L., et al. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215611 · Cited by 37
Chen, L., Huang, H., Zheng, X. W., Li, Y., Chen, J., Tan, B., Liu, Y., Sun, R., Xu, B., Yang, M., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004585 · Cited by 40
Medical Biology of Cancer-Associated Fibroblasts in Pancreatic Cancer
Morgan, A. G., Griffin, M., Kameni, L. E., Wan, D. C., Longaker, M. T., & Norton, J. A. (2023) · Biology · doi:10.3390/biology12081044 · Cited by 44
Zhao, Y., Mei, S., Huang, Y., Chen, J., Zhang, X., & Zhang, P. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.11.025 · Cited by 37
Stouten, I., van Montfoort, N., & Hawinkels, L. J. A. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108707 · Cited by 38
Pietrobono, S., Sabbadini, F., Bertolini, M., Mangiameli, D., Vita, V. D., Fazzini, F., Lunardi, G., Casalino, S., Scarlato, E., Merz, V., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-0104 · Cited by 37
Yin, Z., Yu, R., Zhao, C., Liang, J., Zhang, Y., Su, H., Zhao, J., Wu, H., Xu, S., Zhang, Z., et al. (2023) · Advanced Science · doi:10.1002/advs.202305279 · Cited by 46
Zhang, X., Zhu, R., Yu, D., Wang, J., Yan, Y., & Xu, K. (2023) · Cell Proliferation · doi:10.1111/cpr.13592 · Cited by 37
Zhang, S., You, H., Fan, H., Chen, Y., Song, H., Zhao, Z., Chen, Q., Wang, Y., Tian, Z., Wu, Y., et al. (2025) · Nano Letters · doi:10.1021/acs.nanolett.4c06372 · Cited by 34
Three-dimensional tumor cell cultures employed in virotherapy research
Kloker, L. D., Yurttas, C., & Lauer, U. M. (2018) · Oncolytic Virotherapy · doi:10.2147/ov.s165479 · Cited by 37
Durymanov, M., Kroll, C., Permyakova, A., O'Neill, E., Sulaiman, R., Person, M., & Reineke, J. (2019) · Translational Oncology · doi:10.1016/j.tranon.2018.10.003 · Cited by 34
Linden, C. V., & Corbet, C. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.016 · Cited by 34
Rho-ROCK Signaling in Normal Physiology and as a Key Player in Shaping the Tumor Microenvironment
Porazinski, S. R., Parkin, A., & Pajic, M. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-35582-1_6 · Cited by 36
Metadata
- Authors
- Öhlund, D., Handly-Santana, A., Biffi, G., Elyada, E., Almeida, A. S., Ponz-Sarvise, M., Corbo, V., Oni, T. E., Hearn, S. A., Lee, E. J., Chio, I. I. C., Hwang, C.-I., Tiriac, H., Baker, L. A., Engle, D. D., Feig, C., Kultti, A., Egeblad, M., Fearon, D. T., Crawford, J. M., Clevers, H., Park, Y., & Tuveson, D. A.
- Affiliations
- Cold Spring Harbor Laboratory (US)
- Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724 1
- University of Verona (IT)
- University of Cambridge (GB)
- Hofstra University (US)
- Royal Netherlands Academy of Arts and Sciences (NL)
- ORCID
- Öhlund, Daniel
- Biffi, Giulia
- Almeida, Ana S.
- Corbo, Vincenzo
- Oni, Tobiloba E.
- Hearn, Stephen A.
- Lee, Eun Jung
- Chio, Iok In Christine
- Hwang, Chang-Il
- Tiriac, Hervé
- Baker, Lindsey A.
- Engle, Dannielle D.
- Feig, Christine
- Kultti, Anne
- Egeblad, Mikala
- Fearon, Douglas T.
- Crawford, James M.
- Clevers, Hans
- Park, Youngkyu
- Tuveson, David A.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2017-02-23
- Volume
- 214
- Issue
- 3
- Pages
- 579-596
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC5339682
- OpenAlex
- W2590390825
- Cited by
- 2,590
- References
- 58
- Citations by year
- 2026: 349 · 2025: 333 · 2024: 350 · 2023: 343 · 2022: 335 · 2021: 349 · 2020: 260 · 2019: 144 · 2018: 89 · 2017: 36
- FWCI
- 64.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- KNAW research portal (Royal Academy of Art and Sciences (KNAW)) (publishedVersion, other-oa)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Cork Open Research Archive (University College Cork, Ireland) (acceptedVersion, cc-by)
- Arrow@dit (Dublin Institute of Technology) (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- Lustgarten Foundation
- National Institutes of Health (5P30CA45508-26, 5P50CA101955-07, 1U10CA180944-02, 5U01CA168409-5, 1R01CA188134, 1R01CA190092-03, R50CA311506-01, CA101955 UAB/UMN SPORE, 5T32CA148056, F32CA192904)
- Stand Up to Cancer
- STARR foundation (I7-A718)
- DOD (W81XWH-13-PRCRP-IA)
- Swedish Research Council (537-2013-7277)
- Kempe Foundations (JCK-1301)
- Swedish Society of Medicine (SLS-326921, SLS-250831, SLS-175991, SLS-591551)
- Cancer Research Foundation in Northern Sweden (AMP15-793, LP11-1927)
- Human Frontiers Science Program (LT000403/2014, LT000195/2015-L, LT000190/2013)
- Weizmann Institute of Science
- EMBO (ALTF 1203-2014)
- Italian Ministry of Health (FIRB - RBAP10AHJ)
- Associazione Italiana Ricerca Cancro (18718)
- Damon Runyon Cancer Research Foundation (DRG-2165-13)
- National Cancer Institute (1K99CA204725-01A1)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- pancreatic ductal adenocarcinoma, cancer-associated fibroblasts, CAF heterogeneity, pancreatic stellate cells, myofibroblasts, desmoplastic stroma, alpha-smooth muscle actin, interleukin-6, tumor microenvironment, organoid co-culture, tumor-fibroblast interaction
- MeSH terms
- Actins, Animals, Cells, Cultured, Fibroblasts, Humans, Mice, Inbred C57BL, Pancreatic Neoplasms, Cytokines, Carcinoma, Pancreatic Ductal, STAT3 Transcription Factor, Mice, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.